Relmada Therapeutics Inc is a biotech firm based in Coral Gables, Florida, dedicated to creating new treatments for central nervous system (CNS) diseases and other disorders. Its flagship project, Esmethadone, is a novel compound in advanced clinical trials aimed at addressing major depressive disorder in adults. Founded in 2004, Relmada is at the forefront of exploring innovative therapies to improve mental health outcomes.
Two small-cap biotech names made serious noise today. Xenon Pharmaceuticals (XENE) is trading at $62.76, up 49.6% today, while Relmada Therapeutics (RLMD) sits at $7.17, also up 61.1% Both moves were absolutely eye-popping, but…
Pre-Market Stock Futures: Futures are trading higher as we get ready to start a holiday-shortened trading week after an outstanding triple-witching Friday rally that may have kicked the “Santa Claus” rally into…
